| Literature DB >> 27774345 |
Krishna Kanta Poudel1, Zhibi Huang2, Prakash Raj Neupane3.
Abstract
BACKGROUND: Population based cancer registry is inevitable to measure the indicators of cancer. This retrospective study was conducted to perform the age specific incidence and age standardized rate of cancer by sex, age and sites in Nepal, 2012.Entities:
Keywords: Cancer; ; Nepal. ; age specific; ; incidence;
Year: 2016 PMID: 27774345 PMCID: PMC5073174 DOI: 10.3126/nje.v6i2.15163
Source DB: PubMed Journal: Nepal J Epidemiol
Age specific incidence (ASI) of cancer per 100,000 in both sex in Nepal, 2012
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| 1332893.63 | 3.38 | 1270235.82 | 2.44 | 2.92 |
| 05-09 | 1657607.30 | 4.65 | 1591052.38 | 1.95 | 3.32 |
| 10-14 | 1788542.12 | 3.47 | 1734111.01 | 3.69 | 3.58 |
| 15-19 | 1462795.54 | 6.22 | 1655478.91 | 3.99 | 5.03 |
| 20-24 | 1058334.91 | 7.46 | 1332113.12 | 6.91 | 7.15 |
| 25-29 | 930230.70 | 10.54 | 1177674.60 | 9.85 | 10.15 |
| 30-34 | 781524.89 | 14.46 | 977694.85 | 14.93 | 14.72 |
| 35-39 | 750811.11 | 14.65 | 875629.55 | 31.75 | 23.86 |
| 40-44 | 669055.19 | 24.06 | 735249.27 | 54.68 | 40.09 |
| 45-49 | 583049.37 | 36.70 | 605754.14 | 76.43 | 56.95 |
| 50-54 | 512654.68 | 61.05 | 505884.03 | 99.03 | 79.92 |
| 55-59 | 418238.16 | 83.68 | 410478.91 | 111.09 | 97.26 |
| 60-64 | 373363.35 | 119.99 | 393558.72 | 104.94 | 112.27 |
| 65-69 | 281569.29 | 145.97 | 280216.69 | 140.61 | 143.29 |
| 70-74 | 202038.95 | 188.08 | 198243.07 | 121.06 | 154.89 |
| 75+ | 221615.06 | 152.97 | 231768.27 | 98.37 | 125.06 |
| Total | 13024324.25 | 25.27 | 13975143.34 | 28.06 | 26.71 |
Figure 1:Age specific Incidence (ASI) rate of cancer for both sex in Nepal, 2012
Figure 2:Age specific incidence of five major cancers in males per 100,000 in Nepal, 2012
Age specific incidence of five major cancers per 100,000 in males in Nepal, 2012
| 00-04 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 |
|---|---|---|---|---|---|
| 05-09 | 0.18 | 0.06 | 0.12 | 0.54 | 0.00 |
| 10-14 | 0.06 | 0.00 | 0.00 | 0.34 | 0.00 |
| 15-19 | 0.07 | 0.00 | 0.07 | 0.68 | 0.00 |
| 20-24 | 0.09 | 0.38 | 0.00 | 0.66 | 0.09 |
| 25-29 | 0.86 | 0.11 | 0.00 | 0.32 | 0.11 |
| 30-34 | 1.28 | 0.38 | 0.00 | 0.90 | 0.51 |
| 35-39 | 0.80 | 0.67 | 0.27 | 1.47 | 0.00 |
| 40-44 | 1.35 | 1.05 | 0.45 | 1.05 | 0.30 |
| 45-49 | 4.46 | 3.09 | 0.86 | 1.20 | 0.34 |
| 50-54 | 9.36 | 5.07 | 4.29 | 3.12 | 3.90 |
| 55-59 | 16.74 | 6.46 | 5.26 | 3.11 | 3.83 |
| 60-64 | 27.85 | 12.86 | 9.91 | 2.41 | 4.82 |
| 65-69 | 41.55 | 10.65 | 11.36 | 6.04 | 3.20 |
| 70-74 | 47.52 | 17.82 | 10.39 | 8.41 | 12.87 |
| 75+ | 35.65 | 15.34 | 10.38 | 3.16 | 12.63 |
| Total | 4.45 | 1.84 | 1.31 | 1.14 | 0.98 |
| NHL:Non Hodgkins Lymphoma | |||||
Age specific incidence of five major cancers per 100,000 in females in Nepal, 2012
| 00-04 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 |
|---|---|---|---|---|---|
| 05-09 | 0.06 | 0.06 | 0.00 | 0.06 | 0.00 |
| 10-14 | 0.06 | 0.17 | 0.00 | 0.06 | 0.00 |
| 15-19 | 0.18 | 0.18 | 0.06 | 0.79 | 0.00 |
| 20-24 | 0.08 | 0.53 | 0.23 | 0.98 | 0.15 |
| 25-29 | 0.59 | 1.87 | 0.59 | 0.76 | 0.25 |
| 30-34 | 2.35 | 2.56 | 0.20 | 0.92 | 0.72 |
| 35-39 | 5.25 | 8.57 | 0.57 | 2.28 | 1.03 |
| 40-44 | 11.56 | 15.37 | 1.36 | 3.26 | 2.86 |
| 45-49 | 17.66 | 18.65 | 4.13 | 4.95 | 2.31 |
| 50-54 | 24.12 | 16.21 | 9.49 | 8.10 | 3.36 |
| 55-59 | 26.80 | 17.78 | 11.94 | 5.36 | 5.36 |
| 60-64 | 21.60 | 11.43 | 16.52 | 5.34 | 3.56 |
| 65-69 | 27.12 | 12.49 | 28.91 | 6.42 | 8.21 |
| 70-74 | 20.68 | 12.11 | 28.75 | 5.55 | 5.04 |
| 75+ | 15.96 | 8.63 | 19.42 | 2.16 | 2.59 |
| Total | 5.35 | 4.59 | 2.85 | 1.70 | 1.06 |
Figure 3:Age specific incidence of five major cancers in females per 100,000 in Nepal, 2012
Age Standardized Rate (ASR) of 10 major cancer sites per 100,000 in males and females in Nepal, 2012
| Male | Female | ||
|---|---|---|---|
| Cancer sites | ASR | Cancer sites | ASR |
| Bronchus and Lung | 5.74 | Cervix Uteri | 7.00 |
| Stomach | 2.36 | Breast | 5.70 |
| Larynx | 1.69 | Bronchus and Lung | 3.89 |
| NHL | 1.29 | Ovary | 2.09 |
| Bladder | 1.23 | Stomach | 1.37 |
| Other and unspecified | 1.21 | Gall bladder | 1.37 |
| Brain | 0.84 | Thyroid | 1.01 |
| Rectum | 0.95 | Other and ill defined sites | 0.76 |
| Other and ill defined sites | 0.88 | Brain | 0.64 |
| Connective Subcutaneous and other soft tissue | 0.73 | Rectum | 0.67 |
| NHL:Non Hodgkins Lymphoma | |||